Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mirogabalin for Pain After Total Hip Arthroplasty
NCT05938088Unknown
- Sponsor
- Gangnam Severance Hospital
- Start
- Jul 2023
- Primary completion
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in postoperative pain comparing Mirogabalin Group with Placebo Group (2 arms). Primary endpoint: Numeric Rating Scale at flexion. Status: unknown.
02
Drugs
mirogabalin
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT05938088.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05938088.